CALI - Total Utang marang Modal CalciMedica
CalciMedica, Inc. (CALI) is a biotech startup developing proprietary treatments to combat inflammatory processes. Market dynamics for the securities reflect a total debt-to-equity ratio of 0.00. The company focuses on organ salvage in intensive care units by blocking calcium channels. The project is currently undergoing rigorous FDA reviews as part of late-stage clinical trials for the drug Auxora.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_CALI_-_CalciMedica-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "CALI (CalciMedica) riwayat Total Utang marang Modal saka 11.10.2024 nganti 17.10.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan CalciMedica, Inc.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas CalciMedica, Inc.|CALI - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal CalciMedica Inc|CALI - Gunggung utang perusahaan|Utang marang nilai buku CalciMedica|CALI - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan CalciMedica|Likuiditas cepet calcimedica.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:CalciMedica, Inc.
The ratio compares total liabilities to net assets, determining the business's dependence on borrowed funds and its overall solvency. By analyzing total debt relative to equity, an investor assesses the ability of CalciMedica, Inc. (CALI) to finance costly CRAC channel inhibitor developments without a critical debt load, which is vital for the high-risk biopharmaceutical sector.
Analisis pesaing CalciMedica, Inc.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|Pieris Pharmaceuticals Inc - Total Utang marang Modal|Savara Pharma (SVRA) - Rasio Total Utang marang Ekuitas|RIGL: Total Utang marang Modal|anaptysbio.com (ANAB) - Total Utang marang Modal|Utang marang Ekuitas Astria Therapeutics, Inc.|Utang marang Ekuitas ENGN|Total Utang marang Modal RAPT|Rasio Total Utang marang Ekuitas aerovatetx.com JBIO|Total Utang marang Modal ACRS (Aclaris Therapeutics)|Koefisien Total Utang marang Modal kyvernatx.com (KYTX)|TLSA - Utang marang Ekuitas|Cabaletta Bio Inc. (CABA) - Rasio Total Utang marang Ekuitas|VTYX: Total Utang marang Modal|Utang marang Modal Theratechnologies, Inc (THTX)|AVTX (Avalo Therapeutics, Inc) - Total Utang marang Modal|Rasio Utang marang Ekuitas ELDN (eledon.com)|Total Utang marang Modal AGEN|Koefisien Total Utang marang Modal Climb Bio Inc.|Total Utang marang Modal ZURA (Zura Bio Limited)|ATYR - Rasio Total Utang marang Ekuitas|Adagene Corp - Total Utang marang Modal|IMA - Total Utang marang Modal|STTK (shattucklabs.com) - Rasio Total Utang marang Ekuitas|Equillium - Rasio Kabeh Utang marang Dana Pribadi|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|Immunic Inc (IMUX) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Atara Biotherapeutics (ATRA)|inflarx.de - Rasio Utang marang Ekuitas|Total Utang marang Modal XFOR (X4 Pharmaceuticals, Inc.)|ACET - Rasio Total Utang marang Ekuitas|CELU: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal INmune Bio Corporation INMB|BRNS: Total Utang marang Modal|Rasio Total Utang marang Ekuitas kezarlifesciences.com|SABS (SAB Biotherapeutics, Inc.) - Total Utang marang Modal|Total Utang marang Modal Akari Therapeutics PLC|Utang marang Ekuitas Enlivex Therapeutics (ENLV)|Utang marang Ekuitas QTTB (q32bio.com)|Total Utang marang Modal GOVX (GeoVax Labs, Inc.)|Koefisien Total Utang marang Modal edesabiotech.com (EDSA)|IBIO - Utang marang Ekuitas|Utang Agregat marang Ekuitas CARM|XTLB: Total Utang marang Modal|Bolt Biotherapeutics, Inc. - Rasio Kabeh Utang marang Dana Pribadi|HCWB (HCW Biologics, Inc.) - Total Utang marang Modal|Total Utang marang Modal Aptevo|Utang marang Ekuitas AIM ImmunoTech (AIM)|ADTX (aditxt.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas GRI Bio Corp GRI|XRTX - Rasio Total Utang marang Ekuitas|Vyome Holdings Inc - Total Utang marang Modal|REVB - Total Utang marang Modal|INDP (Indaptus Therapeutics, Inc.) - Rasio Total Utang marang Ekuitas|Scinai Immunotherapeutics Ltd - Rasio Kabeh Utang marang Dana Pribadi|AFMD (Affimed NV) - Total Utang marang Modal|Allakos Therapeutics (ALLK) - Koefisien Total Utang marang Modal|Utang marang Ekuitas HOOKIPA Pharma Inc. (HOOK)|Rasio Total Utang marang Ekuitas igmbio.com IGMS|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|OCEA - Rasio Total Utang marang Ekuitas|TCBP: Rasio Total Utang marang Ekuitas|THRD - Total Utang marang Modal